Leading Financial Service Provider in India | Canara Bank Securities Ltd

Evonile Pharma Ltd.

Nov 12 BSE 1583.60 (+ 10.35 0.66%)

Volume10249

Prev. Close
1573.25

Open Price
1579.60

Today's Low / High

1554.55 1626.75

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

782.35 2079.76

Nov 12 NSE 1589.60(+ 21.50 1.37%)

Volume43262

Prev. Close
1568.10

Open Price
1575.00

Today's Low / High

1555.00 1625.00

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

923.53 2080.33

Market Cap. ( ₹ in Cr. )	5151.36	P/BV	3.40	Book Value ( ₹ )	467.07
52 Week High/Low ( ₹ )	2080/924	FV/ML	5/1	P/E(X)	55.28
Book Closure	11/11/2026	EPS ( ₹ )	28.75	Div Yield (%)	0.00

Standalone

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	5.00	5.00	5.00	5.00	5.00


INCOME
Revenue From Operations [Net]	354.32	356.26	334.04	369.11	387.57
Other Operating Revenues	0.01	0.01	1.03	9.63	12.30
Total Operating Revenues	354.33	356.27	335.07	378.74	399.87

Other Income	38.77	41.96	61.68	58.11	33.19
Total Revenue	393.10	398.23	396.75	436.85	433.06

EXPENSES
Purchase Of Stock-In Trade	210.58	199.07	189.98	199.34	187.26
Changes In Inventories Of FG,WIP And Stock-In Trade	-12.21	3.75	9.86	2.35	-9.13
Employee Benefit Expenses	21.08	18.72	22.96	35.64	101.89
Finance Costs	1.26	0.77	1.49	1.75	4.83
Provisions And Contingencies	-0.13	-0.17	0.17	0.37	0.00
Depreciation And Amortisation Expenses	1.95	2.19	2.61	6.06	9.65
Other Expenses	40.91	43.48	46.84	75.96	92.74
Total Expenses	263.44	267.81	273.91	321.47	387.24

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	129.66	130.42	122.84	115.38	45.82

Exceptional Items	0.00	0.00	0.00	0.00	-49.64
Profit/Loss Before Tax	129.66	130.42	122.84	115.38	-3.82

Tax Expenses-Continued Operations
Current Tax	34.95	29.96	37.63	1.68	0.00
Deferred Tax	1.53	-0.44	0.02	10.34	0.34
Tax For Earlier Years	0.00	0.00	0.00	0.00	-0.44
Total Tax Expenses	36.48	29.52	37.65	12.02	-0.10
Profit/Loss After Tax And Before ExtraOrdinary Items	93.18	100.90	85.19	103.36	-3.72

Profit/Loss From Continuing Operations	93.18	100.90	85.19	103.36	-3.72

Profit/Loss For The Period	93.18	100.90	85.19	103.36	-3.72

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	37.74	40.87	34.50	41.86	-1.51
Diluted EPS (Rs.)	37.74	40.87	34.50	41.86	-1.51

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	61.73	117.28	24.69	24.69
Equity Dividend Rate (%)	0.00	500.00	500.00	950.00	200.00

Markets

Income Statement

INCOME STATEMENT

Evonile Pharma Ltd.